This Hims & Hers Move Could Disrupt Competing Firms
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
A quick guide to reputable sources for index level data, plus tips on choosing datasets and validating their reliability for analysis.
24,978 articlesHims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
A landmark New Mexico case accuses Meta of downplaying safety risks for children on Instagram, Facebook, and WhatsApp...
Broadcom reports AI-related revenue more than doubles in the latest quarter, but the stock trades flat as investors w...
Tether plans a full-scale audit of USDT reserves by a Big Four firm, moving from attestations to a formal audit and s...
A leading AI company hints at a monumental goal: $9 trillion in market value. We explore what that could mean for inv...
Three women leaders dominated the stage at the Reverse Mastermind Summit in Knoxville, outlining new sales strategies...
A clear, practical guide to interpreting the CWK 2026 earnings transcript. Learn what matters, how to quantify signal...
Airfare surged about 15% in April 2026 as fuel prices climbed above $4 per gallon, prompting corporate travel budgets...
When a chief executive sells stock after exercising options, investors often wonder if confidence underpins the move....
A court-appointed examiner released a sweeping 476-page Celsius Network investigation detailing governance gaps and r...
Citi boosts its Broadcom price target to $500 on expectations of solid AI-driven revenue in the upcoming April quarte...
A single market signal suggests SpaceX's IPO could roar, but history warns investors not to blindly chase headlines. ...